220 related articles for article (PubMed ID: 16898185)
1. Autoimmune hemolytic anaemia in the antiphospholipid syndrome.
Rottem M; Krause I; Fraser A; Stojanovich L; Rovensky J; Shoenfeld Y
Lupus; 2006; 15(7):473-7. PubMed ID: 16898185
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.
Ames PRJ; Merashli M; Bucci T; Pastori D; Pignatelli P; Arcaro A; Gentile F
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32527000
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
[No Abstract] [Full Text] [Related]
4. Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis.
Krause I; Leibovici L; Blank M; Shoenfeld Y
Lupus; 2007; 16(3):176-80. PubMed ID: 17432102
[TBL] [Abstract][Full Text] [Related]
5. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome.
Toubi E; Krause I; Fraser A; Lev S; Stojanovich L; Rovensky J; Blank M; Shoenfeld Y
Clin Exp Rheumatol; 2005; 23(4):499-504. PubMed ID: 16095119
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.
Comellas-Kirkerup L; Hernández-Molina G; Cabral AR
Blood; 2010 Oct; 116(16):3058-63. PubMed ID: 20625007
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis.
Merashli M; Arcaro A; Graf M; Gentile F; Ames PRJ
Clin Rheumatol; 2021 May; 40(5):1967-1973. PubMed ID: 33006737
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study.
Djokovic A; Stojanovich L; Stanisavljevic N; Matic P; Colic D; Skrijelj D; Djokic S; Filipovic B
J Clin Rheumatol; 2022 Oct; 28(7):362-366. PubMed ID: 35697016
[TBL] [Abstract][Full Text] [Related]
10. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
[TBL] [Abstract][Full Text] [Related]
11. Primary antiphospholipid antibody syndrome and autoimmune haemolytic anaemia--a rare combination.
Suhail S; Baig MS; Humail SM; Riaz A
J Pak Med Assoc; 2009 Jun; 59(6):413-4. PubMed ID: 19534383
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival.
Artım-Esen B; Çene E; Şahinkaya Y; Erdugan M; Oğuz E; Gül A; Öcal L; İnanç M
Lupus; 2019 Oct; 28(12):1480-1487. PubMed ID: 31558101
[TBL] [Abstract][Full Text] [Related]
13. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
15. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
[TBL] [Abstract][Full Text] [Related]
16. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
[TBL] [Abstract][Full Text] [Related]
17. Livedo Reticularis: An Enigma.
Sangle SR; D'Cruz DP
Isr Med Assoc J; 2015 Feb; 17(2):104-7. PubMed ID: 26223086
[TBL] [Abstract][Full Text] [Related]
18. Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome.
Fujieda Y; Atsumi T; Amengual O; Odani T; Otomo K; Kato M; Oku K; Kon Y; Horita T; Yasuda S; Koike T
Lupus; 2012 Dec; 21(14):1506-14. PubMed ID: 22936124
[TBL] [Abstract][Full Text] [Related]
19. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
20. The hematologic manifestations of the antiphospholipid syndrome.
Uthman I; Godeau B; Taher A; Khamashta M
Blood Rev; 2008 Jul; 22(4):187-94. PubMed ID: 18417261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
